2-[4-[[1-(2-fluorophenyl)-5,6-dihydro-4H-cyclopenta[d]pyrazole-3-carbonyl]amino]oxan-4-yl]acetic acid
C20H22FN3O4 — CID 119214961
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[[1-(2-fluorophenyl)-5,6-dihydro-4H-cyclopenta[d]pyrazole-3-carbonyl]amino]oxan-4-yl]acetic acid
2-[4-[[1-(2-fluorophenyl)-5,6-dihydro-4H-cyclopenta[d]pyrazole-3-carbonyl]amino]oxan-4-yl]acetic acid (PubChem CID 119214961) has the molecular formula C20H22FN3O4 and a molecular weight of 387.41 g/mol. Its IUPAC name is 2-[4-[[1-(2-fluorophenyl)-5,6-dihydro-4H-cyclopenta[d]pyrazole-3-carbonyl]amino]oxan-4-yl]acetic acid.
Molecular Properties
| Compound Name | 2-[4-[[1-(2-fluorophenyl)-5,6-dihydro-4H-cyclopenta[d]pyrazole-3-carbonyl]amino]oxan-4-yl]acetic acid |
|---|---|
| PubChem CID | 119214961 |
| Molecular Formula | C20H22FN3O4 |
| Molecular Weight | 387.41 g/mol |
| Exact Mass | 387.16 |
| IUPAC Name | 2-[4-[[1-(2-fluorophenyl)-5,6-dihydro-4H-cyclopenta[d]pyrazole-3-carbonyl]amino]oxan-4-yl]acetic acid |
| SMILES | O=C(O)CC1(NC(=O)c2nn(-c3ccccc3F)c3c2CCC3)CCOCC1 |
| InChI | InChI=1S/C20H22FN3O4/c21-14-5-1-2-6-16(14)24-15-7-3-4-13(15)18(23-24)19(27)22-20(12-17(25)26)8-10-28-11-9-20/h1-2,5-6H,3-4,7-12H2,(H,22,27)(H,25,26) |
| InChIKey | NITBTRBOQNUDJN-UHFFFAOYSA-N |
| XLogP | 2.25 |
| TPSA | 93.45 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 387.41 |
| LogP ≤ 5 | 2.25 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 119214961 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.